Assembly Biosciences (ASMB) Revenue Growth (5y) (2023 - 2025)

Assembly Biosciences (ASMB) Revenue Growth (5y) (2023 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Assembly Biosciences 431.63 Mn 205.03 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 110.12%
Sep 30, 2025 -20.79%
Jun 30, 2025 -24.55%
Mar 31, 2025 18.21%
Dec 31, 2024 9.07%
Sep 30, 2024 10.10%
Jun 30, 2024 22.61%
Mar 31, 2024 8.29%
Dec 31, 2023 13.91%